Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia
暂无分享,去创建一个
D. Campana | C. Pui | R. Ribeiro | E. Coustan-Smith | J. Taub | J. Rubnitz | S. Pounds | W. Bowman | Lei Shi | W. Bowman | G. Dahl | H. Inaba | C. O’Hear | C. O'Hear